
Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global vascular stents market was valued at USD 10.57 Billion in 2024. The market is anticipated to grow at a CAGR of 5.50% during the forecast period of 2025-2034, with the values likely to reach USD 18.06 Billion by 2034. The market growth is driven by the rising prevalence of cardiovascular diseases (CVDs) across the globe. Patents are focused on advanced technologies such as drug-eluting and covered, among others.
Value in USD Billion
2025-2034
Vascular Stents Patent Landscape Outlook
*this image is indicative*
The Global Vascular Stents Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for vascular stents include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with vascular stents. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within vascular stent technologies.
Patent Valuation Analysis
An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for vascular stent technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with vascular stents.
A comprehensive summary of several patent applications which were filed across different jurisdictions for vascular stents and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.
Detailed analysis of the granted patents across different jurisdictions for vascular stents and their relative value in the IP are covered in the final report.
Vascular stents are small, mesh-like tubes used to maintain blood vessel openings and guarantee appropriate blood flow. They are usually placed in arteries that have blockages brought on by atherosclerosis, a disorder in which plaque accumulates in the arteries. Depending on their composition and purpose, stents can be bioresorbable, drug-eluting, or bare metal. They are frequently used to prevent vessel narrowing and lower the risk of heart attacks and strokes in peripheral artery and coronary artery diseases.
The components of vascular stents include coronary and peripheral. Mesh tubes called peripheral vascular stents are used to maintain adequate blood flow in the peripheral vascular system by keeping blocked or constricted arteries open. To treat peripheral artery disease (PAD) brought on by atherosclerosis, they are frequently implanted in the carotid arteries, kidneys, arms, and legs. By enhancing mobility and reducing symptoms like pain, these stents help lower the risk of major side effects like stroke or limb ischemia.
Technological Advancements in Stent Design is Expected to Boost the Patent Industry Growth
Innovations like drug-eluting stents (DES), bioresorbable stents, and next-generation coated stents are leading to a decline in restenosis rates and improvements in patient outcomes. For instance, in September 2021, Boston Scientific received a U.S. patent for a novel drug-eluting stent that has a sophisticated polymer coating that improves drug release for improved arterial healing.
There is an increase in patent activity which focuses on enhancing the performance of vascular stents. In 2023, 2,378 patents were granted which increased to 2,547 by 2024. Patents covering these technologies are crucial for companies and thus impact the vascular stents patent landscape.
Increasing Prevalence of Cardiovascular Diseases (CVDs) is Expected to Propel Vascular Stents Patent Industry
Vascular stent demand is being driven by the increasing prevalence of peripheral artery disease (PAD) and coronary artery disease (CAD) brought on by the rising aging populations, sedentary lifestyles, and poor diets. The number of stent-based interventions is rising due to the rising global burden of CVDs.
The report will cover the following sections in detail:
Analysis by Technology
Analysis by Product
Analysis by Mode of Delivery
Description 3: -
The breakup based on the mode of delivery includes balloon-expandable and self-expanding. Balloon-expandable vascular stents are crimped onto a balloon catheter. These stiff, mesh-like tubes expand when the balloon is inflated. Strong radial support is offered by these stents, which are frequently used in peripheral and coronary artery interventions, especially in regions like the carotid and renal arteries that demand exact placement. They provide good scaffolding but are less flexible than self-expanding stents because they are made of materials like cobalt-chromium or stainless steel.
The United States is one of the leading jurisdictions for vascular stent patents, having around 93,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.
Among the players with vascular stents patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the vascular stents field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:
The company was founded in 1979 and is based in Maple Grove, Minnesota, in the United States. With cutting-edge technologies like drug-eluting stents, bioresorbable stents, and peripheral vascular stents, it is a major player in the global vascular stents market. In order to enhance patient outcomes in interventional cardiology and endovascular therapies, the company prioritizes innovation and minimally invasive solutions.
Medtronic was established in 1949 and has its headquarters in Dublin, Ireland. Its vascular division is based in California, United States. Offering drug-eluting, bare-metal, and peripheral vascular stents, the company is a major player in the market. Medtronic specializes in cutting-edge, minimally invasive treatments to help patients with peripheral artery disease (PAD) and coronary artery disease (CAD) achieve better results.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include Cook Medical Technologies Llc, Abbott Cardiovascular Systems, and Advanced Cardiovascular System, among others.
The vascular stents patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
Scope of the Report |
Details |
Analysis by Technology |
|
Analysis by Product |
|
Analysis by Mode of Delivery |
|
Analysis by Material |
|
Analysis by End User |
|
Key Players Mentioned |
|
Geographies Covered |
|
Mini Report
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share